Literature DB >> 20949525

Expression and activation of ephexin is altered after spinal cord injury.

Odrick R Rosas1, Johnny D Figueroa, Aranza I Torrado, Mónica Rivera, José M Santiago, Franchesca Konig-Toro, Jorge D Miranda.   

Abstract

Failure of axon regeneration after traumatic spinal cord injury (SCI) is attributable in part to the presence of inhibitory molecular interactions. Recent evidence demonstrates that activation of Eph signaling pathways leads to modulation of growth cone dynamics and repulsion through the activation of ephexin, a novel guanine nucleotide exchange factor (GEF). However, little is known about the expression and modulation of Eph molecular targets in the injured spinal cord. In this study, we determined the expression profile of ephexin after a moderate spinal cord contusion at thoracic level (T10) in young adult rats. Western-blot studies showed increased protein expression in injured rats at 4 and 7 days postinjury (DPI) when compared with control animals. The protein levels returned to normal at 14 DPI and remained steady until 28 DPI. However, immunoprecipitation studies of the phosphorylated ephexin demonstrated that this protein is activated by day 2 until 14 DPI. Expression of ephexin was noticeable in neurons, axons, microglia/macrophages, and reactive astrocytes, and co-localized with EphA3, A4, and A7. These results demonstrate the presence of ephexin in the adult spinal cord and its activation after SCI. Therefore, we show, for the first time, the spatiotemporal pattern of ephexin expression and activation after contusive SCI. Collectively, our data support our previous findings on the putative nonpermissive roles of Eph receptors after SCI and the possible involvement of ephexin in the intracellular cascade of events.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20949525      PMCID: PMC3514508          DOI: 10.1002/dneu.20848

Source DB:  PubMed          Journal:  Dev Neurobiol        ISSN: 1932-8451            Impact factor:   3.964


  57 in total

Review 1.  Multiple roles of EPH receptors and ephrins in neural development.

Authors:  D G Wilkinson
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

Review 2.  Excitatory Eph receptors and adhesive ephrin ligands.

Authors:  R Klein
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

3.  Semiquantitative expression analysis of ephrine-receptor tyrosine kinase mRNA's in a rat model of traumatic brain injury.

Authors:  C Biervert; E Horvath; T Fahrig
Journal:  Neurosci Lett       Date:  2001-11-23       Impact factor: 3.046

4.  NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors.

Authors:  Leonard L Jones; Yu Yamaguchi; William B Stallcup; Mark H Tuszynski
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

5.  EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin.

Authors:  S M Shamah; M Z Lin; J L Goldberg; S Estrach; M Sahin; L Hu; M Bazalakova; R L Neve; G Corfas; A Debant; M E Greenberg
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

6.  Chronically injured supraspinal neurons exhibit only modest axonal dieback in response to a cervical hemisection lesion.

Authors:  J D Houle; Y Jin
Journal:  Exp Neurol       Date:  2001-05       Impact factor: 5.330

7.  Upregulation of EphA receptor expression in the injured adult rat spinal cord.

Authors:  Christopher A Willson; Margarita Irizarry-Ramírez; Hope E Gaskins; Lillian Cruz-Orengo; Johnny D Figueroa; Scott R Whittemore; Jorge D Miranda
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

8.  The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function.

Authors:  J T Henderson; J Georgiou; Z Jia; J Robertson; S Elowe; J C Roder; T Pawson
Journal:  Neuron       Date:  2001-12-20       Impact factor: 17.173

9.  Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors.

Authors:  Mari A Takasu; Matthew B Dalva; Richard E Zigmond; Michael E Greenberg
Journal:  Science       Date:  2001-12-20       Impact factor: 47.728

10.  Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells.

Authors:  Richard A Asher; Daniel A Morgenstern; Morven C Shearer; Kathryn H Adcock; Penka Pesheva; James W Fawcett
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

View more
  10 in total

1.  Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats.

Authors:  Jennifer M Colón; Pablo A González; Ámbar Cajigas; Wanda I Maldonado; Aranza I Torrado; José M Santiago; Iris K Salgado; Jorge D Miranda
Journal:  Exp Neurol       Date:  2017-10-13       Impact factor: 5.330

2.  Critical role of EphA4 in early brain injury after subarachnoid hemorrhage in rat.

Authors:  Ruiming Fan; Budbazar Enkhjargal; Richard Camara; Feng Yan; Lei Gong; Jiping Tang; Yangmei Chen; John H Zhang
Journal:  Exp Neurol       Date:  2017-07-08       Impact factor: 5.330

3.  Expression profile and role of EphrinA1 ligand after spinal cord injury.

Authors:  Luz C Arocho; Johnny D Figueroa; Aranza I Torrado; José M Santiago; Ariel E Vera; Jorge D Miranda
Journal:  Cell Mol Neurobiol       Date:  2011-05-21       Impact factor: 5.046

4.  Dietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injury.

Authors:  Johnny D Figueroa; Kathia Cordero; Miguel S Llán; Marino De Leon
Journal:  J Neurotrauma       Date:  2013-02-06       Impact factor: 5.269

Review 5.  Eph/ephrin signaling in epidermal differentiation and disease.

Authors:  Samantha Lin; Bingcheng Wang; Spiro Getsios
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

6.  Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.

Authors:  Jennifer M Colón; Aranza I Torrado; Ámbar Cajigas; José M Santiago; Iris K Salgado; Yaría Arroyo; Jorge D Miranda
Journal:  J Neurotrauma       Date:  2016-04-08       Impact factor: 5.269

7.  Long-term treatment with PP2 after spinal cord injury resulted in functional locomotor recovery and increased spared tissue.

Authors:  Odrick R Rosas; Aranza I Torrado; Jose M Santiago; Ana E Rodriguez; Iris K Salgado; Jorge D Miranda
Journal:  Neural Regen Res       Date:  2014-12-15       Impact factor: 5.135

8.  Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss.

Authors:  Emma Macdonald; Margaret Cassidy; Bradford E Hall; Sijung Yun; Matthew R Sapio; Pradipta Ray; Megan Doty; Pranavi Nara; Michael D Burton; Stephanie Shiers; Abhik Ray-Chaudhury; Andrew J Mannes; Theodore J Price; Michael J Iadarola; Ashok B Kulkarni
Journal:  Sci Rep       Date:  2022-03-18       Impact factor: 4.996

Review 9.  Emerging Roles of Ephexins in Physiology and Disease.

Authors:  Kwanhyeong Kim; Sang-Ah Lee; Daeho Park
Journal:  Cells       Date:  2019-01-24       Impact factor: 6.600

10.  The effect of journal guidelines on the reporting of antibody validation.

Authors:  Joyce M Hoek; Wytske M Hepkema; Willem Halffman
Journal:  PeerJ       Date:  2020-06-03       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.